Explore the Top 10 CRO Companies in USA, comparing clinical trial, therapeutic, and regulatory expertise to help you evaluate the right CRO for your study.
Table of Contents
Choosing the right Contract Research Organization (CRO) can influence clinical trial execution, regulatory planning, timelines, data quality, and development costs. With pharmaceutical and biotechnology companies evaluating providers based on therapeutic experience, trial phase capabilities, geographic reach, data management, and regulatory knowledge, this Top 10 CRO Companies in USA list provides an overview of established organizations supporting different stages of clinical development. Each company has different capabilities, so the right selection depends on the requirements of the individual clinical program.
The US CRO market includes large global organizations as well as specialized providers offering clinical development, laboratory, regulatory, safety, data management, and medical writing services. Before selecting a CRO, it is important to assess experience in the required therapeutic area, study phase, patient population, geographic region, and regulatory pathway.
How to Choose a CRO in the USA
A CRO should be evaluated on more than its company size. Important factors include experience with the required indication, Phase I to Phase IV capabilities, site access, patient recruitment, clinical monitoring, data management, pharmacovigilance, medical writing, and regulatory support.Regulatory experience is also important when a program involves FDA interactions, IND submissions, clinical trial documentation, safety reporting, or later stage regulatory submissions. Understanding these capabilities before starting a project can help create a more suitable development strategy.
Comparison of Top 10 CRO Companies in USA
| Rank | CRO Company | Key Therapeutic Expertise | Clinical Trial Expertise | Regulatory Expertise | Best Suited For | Website |
| 1 | IQVIA | Oncology, immunology, neurology, cardiovascular, rare disease | Phase I to IV, clinical development and RWE | FDA, EMA, global regulatory strategy and submissions | Large global development programs | IQVIA |
| 2 | ICON | Oncology, cardiovascular, CNS, rare disease, immunology | Phase II to IIIb, clinical operations and device studies | FDA, EMA, PMDA, IND and CTA support | Global clinical development programs | ICON |
| 3 | ProRelix Research | Oncology, CNS, endocrinology, ophthalmology, immunology and dermatology | Phase I to IV, bioequivalence, devices, RWE, hybrid and decentralized trials | FDA, ICH GCP, ethics documentation and regulatory affairs | Pharmaceutical and biotechnology development programs | ProRelix Research |
| 4 | Parexel | Oncology, rare disease, immunology, neuroscience | Early development, Phase II to IV and clinical development | FDA, EMA, NMPA and global regulatory strategy | Integrated clinical and regulatory development | Parexel |
| 5 | Fortrea | Oncology, cardiovascular, CNS, infectious disease | Phase I to IV and global clinical trials | Global regulatory strategy and clinical support | Early phase and global development | Fortrea |
| 6 | Labcorp | Oncology, rare disease, biologics and advanced therapies | Clinical testing, bioanalysis, biomarkers and diagnostics | Scientific and regulatory development support | Laboratory and biomarker intensive programs | Labcorp |
| 7 | Syneos Health | Oncology, CNS, immunology, rare disease | Early to late phase and decentralized solutions | IND, IMPD, NDA, BLA and global regulatory affairs | Integrated clinical development | Syneos Health |
| 8 | Medpace | Oncology, hematology, cardiovascular, CNS and rare disease | Phase I to IV, advanced therapies and medical devices | Regulatory services and clinical development support | Therapeutically focused programs | Medpace |
| 9 | Precision for Medicine | Oncology, rare disease, immunology and advanced therapies | Precision medicine and biomarker studies | Clinical and regulatory support | Biomarker driven programs | Precision for Medicine |
| 10 | PPD, part of Thermo Fisher Scientific | Oncology, infectious disease, immunology and neuroscience | Phase I to IV, clinical operations, patient recruitment, data management and biostatistics | Regulatory strategy, submissions, clinical documentation and health authority support | Global clinical development programs | PPD |
Top 10 CRO Companies in USA
1. IQVIA
IQVIA provides clinical development, technology, data, safety, and regulatory services across the drug development lifecycle. Its regulatory services include regulatory strategy, agency interactions, submissions, labeling, publishing, and lifecycle management. IQVIA also supports clinical and regulatory planning across global markets.
| Area | IQVIA |
| Therapeutic Expertise | Oncology, immunology, neurology, cardiovascular, rare disease and other areas |
| Clinical Expertise | Phase I to IV, clinical development and real world evidence |
| Regulatory Expertise | FDA, EMA and global regulatory strategy, agency interactions and submissions |
| Best Suited For | Large and complex global development programs |
Website: IQVIA Official Website
2. ICON
ICON supports pharmaceutical, biotechnology, and medical device companies through clinical development, clinical operations, site and patient services, and regulatory consulting. Its regulatory services cover clinical trial submissions, agency interactions, regulatory strategy, IND support, and global regulatory requirements.
| Area | ICON |
| Therapeutic Expertise | Oncology, cardiovascular, CNS, rare disease, immunology and other areas |
| Clinical Expertise | Phase II to IIIb, clinical operations, adaptive trials and medical device studies |
| Regulatory Expertise | FDA, EMA, PMDA, IND, CTA and global regulatory support |
| Best Suited For | Global clinical development programs requiring integrated services |
Website: ICON Official Website
3. ProRelix Research
ProRelix Research is a Clinical Research Organization (CRO) with offices in the USA and India along with site networks in Europe and SouthEast Asia supporting the clinical development of innovative new healthcare inventions and innovations to improve the health of patients.
The organization supports clinical development across Phase I to Phase IV and provides services including clinical operations, medical writing, data management, pharmacovigilance, and regulatory support. Its clinical capabilities cover pharmaceuticals, biotechnology programs, medical devices, bioequivalence, real world evidence, hybrid trials, and decentralized clinical trials.
ProRelix Research has experience across therapeutic areas including oncology, CNS, endocrinology, ophthalmology, immunology, dermatology, and other disease areas. Its regulatory capabilities include FDA requirements, ICH GCP, ethics committee documentation, clinical trial documentation, and regulatory affairs support.
| Area | ProRelix Research |
| Therapeutic Expertise | Oncology, CNS, endocrinology, ophthalmology, immunology, dermatology and other areas |
| Clinical Expertise | Phase I to IV, bioequivalence, medical devices, RWE, hybrid and decentralized trials |
| Regulatory Expertise | FDA, ICH GCP, ethics submissions, clinical documentation and regulatory affairs |
| Best Suited For | Pharmaceutical and biotechnology companies seeking flexible clinical development support |
Website: ProRelix Research Official Website
4. Parexel
Parexel provides clinical development, regulatory, patient engagement, medical communications, real world evidence, and pharmacovigilance services. Its capabilities support programs across different stages of development and multiple therapeutic areas.
| Area | Parexel |
| Therapeutic Expertise | Oncology, rare disease, immunology, neuroscience and other areas |
| Clinical Expertise | Early development, Phase II to IV and clinical development |
| Regulatory Expertise | FDA, EMA, NMPA and global regulatory strategy |
| Best Suited For | Integrated clinical and regulatory development |
Website: Parexel Official Website
5. Fortrea
Fortrea provides clinical development services covering early and late stage research, clinical operations, patient recruitment, data management, safety, and related development functions. The company reports a network of more than 15,000 investigators and 5,500 sites and provides full service and functional service models.
| Area | Fortrea |
| Therapeutic Expertise | Oncology, cardiovascular, CNS, infectious disease and other areas |
| Clinical Expertise | Phase I to IV, early development and global clinical trials |
| Regulatory Expertise | Global regulatory strategy and clinical development support |
| Best Suited For | Early phase and global clinical development programs |
Website: Fortrea Official Website
6. Labcorp
Labcorp supports biopharmaceutical development through clinical laboratory services, bioanalysis, diagnostics, biomarkers, and drug development services. Its capabilities extend from preclinical research through clinical trial testing and diagnostic development.
| Area | Labcorp |
| Therapeutic Expertise | Oncology, rare disease, biologics, cell and gene therapy and other areas |
| Clinical Expertise | Clinical testing, bioanalysis, biomarkers, genomics and diagnostics |
| Regulatory Expertise | Scientific and regulatory support related to drug development |
| Best Suited For | Programs requiring laboratory, biomarker or diagnostic capabilities |
Website:Labcorp Official Website
7. Syneos Health
Syneos Health provides clinical development services from early phase through late phase, including study start up, clinical operations, safety and pharmacovigilance, medical writing, biostatistics, and regulatory services. Its regulatory portfolio includes US IND submissions, EU IMPD submissions, agency meetings, NDA and BLA support, and regulatory strategy.
| Area | Syneos Health |
| Therapeutic Expertise | Oncology, CNS, immunology, rare disease and other areas |
| Clinical Expertise | Early to late phase, clinical operations, data and decentralized trials |
| Regulatory Expertise | US IND, EU IMPD, agency meetings, NDA, BLA and global regulatory affairs |
| Best Suited For | Integrated clinical development and functional service models |
Website: Syneos Health Official Website
8. Medpace
Medpace provides CRO services across clinical development, regulatory affairs, study start up, clinical trial management, monitoring, data management, biostatistics, medical writing, safety, pharmacovigilance, and quality assurance. Its model covers projects from early planning through study closeout.
| Area | Medpace |
| Therapeutic Expertise | Oncology, hematology, cardiovascular, CNS, endocrine, ophthalmology and rare disease |
| Clinical Expertise | Phase I to IV, cell and gene therapy, medical devices and clinical operations |
| Regulatory Expertise | Regulatory services, submissions, clinical development and agency support |
| Best Suited For | Therapeutically focused clinical development programs |
Website: Medpace Official Website
9. Precision for Medicine
Precision for Medicine focuses on clinical development and precision medicine programs, with capabilities relevant to biomarkers, oncology, rare disease, immunology, and advanced therapies. Its services are particularly relevant to programs where biomarker and laboratory requirements are closely connected to clinical development.
| Area | Precision for Medicine |
| Therapeutic Expertise | Oncology, rare disease, immunology and advanced therapies |
| Clinical Expertise | Precision medicine, biomarker studies, early and late phase research |
| Regulatory Expertise | Clinical and regulatory support for specialized development programs |
| Best Suited For | Biomarker driven and precision medicine studies |
Website: Precision for Medicine Official Website
10. PPD, Part of Thermo Fisher Scientific
PPD, part of Thermo Fisher Scientific, provides clinical research and development services to pharmaceutical, biotechnology, and medical device companies. Its services cover clinical trial management, site and patient services, data management, biostatistics, medical writing, pharmacovigilance, and regulatory support.
PPD supports clinical programs across different development stages and therapeutic areas, including oncology, immunology, infectious diseases, cardiovascular conditions, central nervous system disorders, and rare diseases. Its regulatory capabilities include regulatory strategy, clinical documentation, submissions, and health authority support.
| Area | PPD, Part of Thermo Fisher Scientific |
| Therapeutic Expertise | Oncology, immunology, infectious disease, cardiovascular, CNS and rare disease |
| Clinical Expertise | Phase I to IV, clinical operations, patient recruitment, data management and biostatistics |
| Regulatory Expertise | Regulatory strategy, submissions, clinical documentation and health authority support |
| Best Suited For | Global clinical development programs requiring integrated CRO services |
Website: PPD Official Website
What to Consider Before Selecting a CRO
| Evaluation Factor | What to Check |
| Therapeutic Expertise | Experience with the disease area and patient population |
| Trial Phase | Relevant Phase I, II, III or IV experience |
| Regulatory Support | FDA submissions, INDs, agency meetings and compliance |
| Clinical Operations | Site selection, recruitment, monitoring and study management |
| Data Management | EDC, data cleaning, coding and database management |
| Medical Writing | Protocols, CSRs, investigator documents and submission documents |
| Safety | AE, SAE, SUSAR and pharmacovigilance capabilities |
| Geographic Reach | US coverage and international site capabilities |
| Technology | EDC, eConsent, remote monitoring and decentralized trial capabilities |
| Communication | Reporting structure, escalation process and project visibility |
The largest CRO is not automatically the right fit for every clinical development program. Companies should compare therapeutic expertise, clinical trial experience, regulatory capabilities, geographic coverage, site access, technology, communication processes, and the level of operational support required.
For emerging biotechnology companies as well as established pharmaceutical organizations, the evaluation should begin with the needs of the study. A CRO with relevant therapeutic and regulatory experience can provide more practical value when its capabilities closely match the development program.The CROs included in this list represent different service models and areas of expertise. Comparing their clinical capabilities, regulatory experience, therapeutic knowledge, and operational fit can help companies create a more informed shortlist for their next clinical development program.
FAQs
A CRO supports clinical trials through study management, monitoring, data management, medical writing, safety, and regulatory services.
Consider therapeutic expertise, trial phase experience, regulatory knowledge, site capabilities, geographic reach, technology, and project requirements.
CROs may support FDA submissions, IND preparation, regulatory strategy, agency interactions, ethics documentation, and clinical trial compliance.
IQVIA, ICON, ProRelix Research, Parexel, Fortrea, Syneos Health, and Medpace support clinical development across multiple trial phases.
ProRelix Research supports clinical development through offices in the USA and India, with site networks across Europe and Southeast Asia.
